Semiparametric Joint Inference for Sensitivity and Specificity at the Youden-Optimal Cut-Off
Siyan Liu, Qinglong Tian, Chunlin Wang, Pengfei Li

TL;DR
This paper introduces a semiparametric method for jointly estimating sensitivity and specificity at the Youden-optimal cut-off, improving accuracy and efficiency over existing methods, with applications to COVID-19 antibody data.
Contribution
It develops a semiparametric framework using empirical likelihood for joint inference on sensitivity and specificity at the optimal cut-off, addressing dependence and efficiency issues.
Findings
The method achieves accurate coverage in simulations.
It outperforms parametric and nonparametric alternatives.
Application to COVID-19 data demonstrates practical utility.
Abstract
Sensitivity and specificity evaluated at an optimal diagnostic cut-off are fundamental measures of classification accuracy when continuous biomarkers are used for disease diagnosis. Joint inference for these quantities is challenging because their estimators are evaluated at a common, data-driven threshold estimated from both diseased and healthy samples, inducing statistical dependence. Existing approaches are largely based on parametric assumptions or fully nonparametric procedures, which may be sensitive to model misspecification or lack efficiency in moderate samples. We propose a semiparametric framework for joint inference on sensitivity and specificity at the Youden-optimal cut-off under the density ratio model. Using maximum empirical likelihood, we derive estimators of the optimal threshold and the corresponding sensitivity and specificity, and establish their joint asymptotic…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods and Inference · Single-cell and spatial transcriptomics · SARS-CoV-2 detection and testing
